TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
What is Market Cap of TransCode Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. TransCode Therapeutics Inc market cap is $8.82M.
What is the 52-week high for TransCode Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. TransCode Therapeutics Inc 52 week high is $739.20 as of October 03, 2025.
What is the 52-week low for TransCode Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. TransCode Therapeutics Inc 52 week low is $6.15 as of October 03, 2025.
What is TransCode Therapeutics Inc stock price today?
TransCode Therapeutics Inc stock price today is $10.49.
What was TransCode Therapeutics Inc stock price yesterday?
TransCode Therapeutics Inc stock price yesterday was $10.58.
What is the PE ratio of TransCode Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. TransCode Therapeutics Inc’s P/E ratio is -0.03.
What is the Price-to-Book ratio of TransCode Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. TransCode Therapeutics Inc P/B ratio is 1.4347.
What is the 50-day moving average of TransCode Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. TransCode Therapeutics Inc 50-day moving average is $10.83.
How many employess does TransCode Therapeutics Inc has?